Peers of Neogenomics Inc (NEO)
Side-by-side comparison
Health Care · Health Care Providers & Services
Share price divided by profit per share over the last 12 months. Shows how many dollars investors pay for each $1 of yearly profit.
Latest P/E Ratio
-41.67x
As of Oct 14, 2026
Beyond P/E Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/E Ratio |
|---|---|
| Oct 14, 2026 | -41.67x |
| Oct 13, 2026 | -41.08x |
| Oct 12, 2026 | -39.95x |
| Oct 9, 2026 | -40.31x |
| Oct 8, 2026 | -39.50x |
| Oct 7, 2026 | -39.38x |
| Oct 6, 2026 | -40.70x |
| Oct 5, 2026 | -47.17x |
P/E Ratio = Current Stock Price ÷ Trailing 12-Month (TTM) Diluted EPS (or Market Cap ÷ TTM Net Income). Chartloom divides stock price by trailing twelve-month EPS, calculated by dividing TTM net income by the weighted-average share count from filings. Note: Variations in share-count conventions across data providers may cause slight differences in reported P/E multiples.
Trailing P/E is based on reported GAAP results and is one of the most widely used valuation metrics.
Read the general P/E Ratio definition, formula, and analyst usage guide.
P/E Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison